Hepatic fibrosis, advanced fibrosis
ICD-10 K74.02 is a billable code used to indicate a diagnosis of hepatic fibrosis, advanced fibrosis.
Hepatic fibrosis, advanced fibrosis, is a progressive condition characterized by excessive accumulation of extracellular matrix proteins, leading to scarring of the liver tissue. Clinically, patients may present with symptoms such as fatigue, jaundice, ascites, and abdominal discomfort, although advanced fibrosis can often be asymptomatic until significant liver damage occurs. The liver, a vital organ in the digestive system, plays a crucial role in metabolism, detoxification, and synthesis of proteins. As fibrosis progresses, it can lead to cirrhosis, portal hypertension, and liver failure. Diagnostic considerations include imaging studies such as ultrasound, CT, or MRI, and liver biopsy, which can confirm the degree of fibrosis. Non-invasive methods like elastography are also increasingly used to assess liver stiffness as an indicator of fibrosis severity. Regular monitoring and early intervention are essential to manage underlying causes, such as chronic hepatitis or alcohol use, to prevent further liver damage.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K74.02 specifically covers advanced hepatic fibrosis, which may arise from chronic liver diseases such as hepatitis B and C, alcoholic liver disease, and non-alcoholic fatty liver disease (NAFLD). It is essential to differentiate it from other stages of fibrosis and cirrhosis.
K74.02 should be used when the patient has been diagnosed with advanced fibrosis, typically indicated by a significant increase in liver stiffness or confirmed by biopsy. It is crucial to use this code when there is clear evidence of advanced scarring, as opposed to mild or moderate fibrosis.
Documentation supporting K74.02 should include clinical notes detailing the patient's history of liver disease, results from imaging studies or liver biopsy confirming advanced fibrosis, and any relevant laboratory results indicating liver function impairment.
